Bruce JN - Search Results

1

Restoration of p53 function for selective Fas-mediated apoptosis in human and rat glioma cells in vitro and in vivo by a p53 COOH-terminal peptide.

Senatus PB, Li Y, Mandigo C, Nichols G, Moise G, Mao Y, Brown MD, Anderson RC, Parsa AT, Brandt-Rauf PW, Bruce JN, Fine RL. Senatus PB, et al. Among authors: bruce jn. Mol Cancer Ther. 2006 Jan;5(1):20-8. doi: 10.1158/1535-7163.MCT-05-0181. Mol Cancer Ther. 2006. PMID: 16432159

2

Frequent type 2 neurofibromatosis gene transcript mutations in sporadic intramedullary spinal cord ependymomas.

Birch BD, Johnson JP, Parsa A, Desai RD, Yoon JT, Lycette CA, Li YM, Bruce JN. Birch BD, et al. Among authors: bruce jn. Neurosurgery. 1996 Jul;39(1):135-40. doi: 10.1097/00006123-199607000-00026. Neurosurgery. 1996. PMID: 8805149

3

Intracerebral clysis in a rat glioma model.

Bruce JN, Falavigna A, Johnson JP, Hall JS, Birch BD, Yoon JT, Wu EX, Fine RL, Parsa AT. Bruce JN, et al. Neurosurgery. 2000 Mar;46(3):683-91. doi: 10.1097/00006123-200003000-00031. Neurosurgery. 2000. PMID: 10719865

4

Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.

Parsa AT, Chakrabarti I, Hurley PT, Chi JH, Hall JS, Kaiser MG, Bruce JN. Parsa AT, et al. Among authors: bruce jn. Neurosurgery. 2000 Oct;47(4):993-9; discussion 999-1000. doi: 10.1097/00006123-200010000-00050. Neurosurgery. 2000. PMID: 11014444

5

Genetic basis of intramedullary spinal cord tumors and therapeutic implications.

Parsa AT, Fiore AJ, McCormick PC, Bruce JN. Parsa AT, et al. Among authors: bruce jn. J Neurooncol. 2000 May;47(3):239-51. doi: 10.1023/a:1006422607122. J Neurooncol. 2000. PMID: 11016741 Review.

6

Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.

Kaiser MG, Parsa AT, Fine RL, Hall JS, Chakrabarti I, Bruce JN. Kaiser MG, et al. Among authors: bruce jn. Neurosurgery. 2000 Dec;47(6):1391-8; discussion 1398-9. Neurosurgery. 2000. PMID: 11126910

7

Why neurosurgeons should care about stem cells.

Bruce JN, Parsa AT. Bruce JN, et al. Neurosurgery. 2001 Jan;48(1):243-4. doi: 10.1227/00006123-200101000-00053. Neurosurgery. 2001. PMID: 11152358 No abstract available.

8

Immunomodulation of glioma cells after gene therapy: induction of major histocompatibility complex class I but not class II antigen in vitro.

Parsa AT, Chi JH, Hurley PT, Jeyapalan SA, Bruce JN. Parsa AT, et al. Among authors: bruce jn. Neurosurgery. 2001 Sep;49(3):681-8; discussion 688-9. doi: 10.1097/00006123-200109000-00028. Neurosurgery. 2001. PMID: 11523680

9

Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro.

Anderson RC, Elder JB, Brown MD, Mandigo CE, Parsa AT, Kim PD, Senatus P, Anderson DE, Bruce JN. Anderson RC, et al. Among authors: bruce jn. Clin Immunol. 2002 Jan;102(1):84-95. doi: 10.1006/clim.2001.5152. Clin Immunol. 2002. PMID: 11781071

10

CP248, a derivative of exisulind, causes growth inhibition, mitotic arrest, and abnormalities in microtubule polymerization in glioma cells.

Yoon JT, Palazzo AF, Xiao D, Delohery TM, Warburton PE, Bruce JN, Thompson WJ, Sperl G, Whitehead C, Fetter J, Pamukcu R, Gundersen GG, Weinstein IB. Yoon JT, et al. Among authors: bruce jn. Mol Cancer Ther. 2002 Apr;1(6):393-404. Mol Cancer Ther. 2002. PMID: 12477052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page